1. Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study. Issue 6 (1st April 2022) Authors: Kister, Ilya; Patskovsky, Yury; Curtin, Ryan; Pei, Jinglan; Perdomo, Katherine; Rimler, Zoe; Voloshyna, Iryna; Samanovic, Marie I.; Cornelius, Amber R.; Velmurugu, Yogambigai; Nyovanie, Samantha; Kim, Joseph J.; Tardio, Ethan; Bacon, Tamar E.; Zhovtis Ryerson, Lana; Raut, Pranil; Pedotti, Rosetta... Journal: Annals of neurology Issue: Volume 91:Issue 6(2022) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies. Issue 10 (27th September 2022) Authors: Kister, Ilya; Curtin, Ryan; Pei, Jinglan; Perdomo, Katherine; Bacon, Tamar E.; Voloshyna, Iryna; Kim, Joseph; Tardio, Ethan; Velmurugu, Yogambigai; Nyovanie, Samantha; Valeria Calderon, Andrea; Dibba, Fatoumatta; Stanzin, Igda; Samanovic, Marie I.; Raut, Pranil; Raposo, Catarina; Priest, Jessica;... Journal: Annals of clinical and translational neurology Issue: Volume 9:Issue 10(2022) Page Start: 1643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗